Alliancebernstein L.P. Gilead Sciences, Inc. Transaction History

Alliancebernstein L.P.

$278 Billion
Q2 2024

A detailed history of Alliancebernstein L.P. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 6,677,368 shares of GILD stock, worth $558 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

6,677,368

Previous 6,978,668 4.32%

Holding current value

$558 Million

Previous $511 Million 10.38%

% of portfolio

0.16%

Previous 0.19%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $19 Million - $22 Million	-301,300 Reduced 4.32%	6,677,368 $458 Million
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $20.6 Million - $25.1 Million	-287,847 Reduced 3.96%	6,978,668 $511 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $4.74 Million - $5.38 Million	64,689 Added 0.9%	7,266,515 $589 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $11.5 Million - $12.6 Million	-155,991 Reduced 2.12%	7,201,826 $540 Million
Q2 2023 Aug 15, 2023	BUY	$76.01 - $86.7 $28.3 Million - $32.3 Million	371,998 Added 5.33%	7,357,817 $567 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $239 Million - $273 Million	3,096,039 Added 79.59%	6,985,819 $580 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $131 Million - $188 Million	2,101,626 Added 117.53%	3,889,780 $334 Million
Q3 2022 Nov 15, 2022	BUY	$59.54 - $68.01 $1.66 Million - $1.9 Million	27,918 Added 1.59%	1,788,154 $110 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $5.89 Million - $6.63 Million	101,996 Added 6.15%	1,760,236 $109 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $810,706 - $1.02 Million	13,997 Added 0.85%	1,658,240 $98.6 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $3.3 Million - $3.74 Million	-50,806 Reduced 3.0%	1,644,243 $119 Million
Q3 2021 Nov 10, 2021	SELL	$67.69 - $73.03 $11 Million - $11.8 Million	-162,101 Reduced 8.73%	1,695,049 $118 Million
Q2 2021 Jul 30, 2021	SELL	$63.47 - $69.35 $15.6 Million - $17.1 Million	-246,438 Reduced 11.72%	1,857,150 $128 Million
Q1 2021 May 06, 2021	BUY	$60.0 - $68.46 $15.1 Million - $17.3 Million	252,298 Added 13.63%	2,103,588 $136 Million
Q4 2020 Feb 08, 2021	SELL	$56.65 - $64.55 $8.58 Million - $9.78 Million	-151,527 Reduced 7.57%	1,851,290 $108 Million
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $17.1 Million - $21.5 Million	-275,247 Reduced 12.08%	2,002,817 $127 Million
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $1.72 Million - $1.99 Million	23,747 Added 1.05%	2,278,064 $175 Million
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $294 Million - $377 Million	-4,701,747 Reduced 67.59%	2,254,317 $169 Million
Q4 2019 Feb 18, 2020	SELL	$61.62 - $67.78 $120 Million - $132 Million	-1,943,346 Reduced 21.84%	6,956,064 $452 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $141 Million - $156 Million	-2,253,764 Reduced 20.21%	8,899,410 $564 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $2.74 Million - $3.07 Million	44,302 Added 0.4%	11,153,174 $754 Million
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $8.3 Million - $9.29 Million	-132,660 Reduced 1.18%	11,108,872 $722 Million
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $39.4 Million - $51.4 Million	650,280 Added 6.14%	11,241,532 $703 Million
Q3 2018 Nov 08, 2018	BUY	$71.28 - $78.92 $17.2 Million - $19.1 Million	241,790 Added 2.34%	10,591,252 $818 Million
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $25.3 Million - $29.6 Million	390,460 Added 3.92%	10,349,462 $733 Million
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $4.11 Million - $5.01 Million	56,369 Added 0.57%	9,959,002 $751 Million
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $10.7 Million - $12.5 Million	-149,861 Reduced 1.49%	9,902,633 $709 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $725 Million - $859 Million	10,052,494	10,052,494 $814 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Gilead Sciences, Inc. Transaction History